SRK-439 for Safety in Healthy Adults
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial evaluates the safety and tolerability of a new treatment called SRK-439 in healthy adults. As a Phase 1 trial, it primarily ensures the drug does not cause unexpected problems. The study consists of two parts: one where participants receive a single dose and another with multiple doses. Individuals who are generally healthy and have not recently used muscle-enhancing drugs or certain other treatments may qualify for this trial. Participants will be among the first to receive this new treatment, aiding researchers in understanding its effects in people.
Is there any evidence suggesting that SRK-439 is likely to be safe for humans?
An earlier study tested SRK-439 on healthy adults to assess its safety and tolerability in single and multiple doses. So far, these studies have found no serious safety issues. However, SRK-439 remains under investigation, and its safety is not fully established. The FDA has not approved it for any use. Early lab tests suggest potential benefits for weight management and muscle preservation, but further research is necessary to confirm its safety in humans.12345
Why do researchers think this study treatment might be promising?
SRK-439 is unique because it represents a potentially new class of treatment options that are currently being explored for various medical conditions. Unlike standard treatments that often rely on well-known mechanisms such as enzyme inhibition or receptor antagonism, SRK-439 is thought to operate through a novel mechanism, which could potentially offer a different approach to treating diseases. Researchers are excited about SRK-439 as it could provide an alternative for patients who do not respond well to existing therapies, potentially improving effectiveness and reducing side effects.
What evidence suggests that SRK-439 could be effective?
This trial will evaluate the safety of SRK-439 in healthy adults. Studies have shown that SRK-439 might aid in weight management by preserving lean muscle during weight loss. Early research suggests it could improve body composition, potentially maintaining muscle while reducing fat. Although the safety and effectiveness of SRK-439 in humans remain unknown, early animal studies indicate it might assist with conditions like obesity. Research also hints at possible improvements in muscle strength and exercise endurance. However, these findings are based on animal studies, and further research is necessary to determine if these effects occur in humans.13456
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment Part A
Participants receive a single dose of SRK-439 or matching placebo
Treatment Part B
Participants receive multiple doses of SRK-439 or matching placebo
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- SRK-439
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Participants will be treated with multiple doses of SRK-439 or matching placebo.
Participants will be treated with a single dose of SRK-439 or matching placebo.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Scholar Rock, Inc.
Lead Sponsor
Citations
1.
investors.scholarrock.com
investors.scholarrock.com/news-releases/news-release-details/scholar-rock-announces-new-srk-439-preclinical-data-showing/Scholar Rock Announces New SRK-439 Preclinical Data ...
Based on preclinical data, SRK-439 has the potential to support healthier weight management by preserving lean mass during weight loss. The ...
2.
investors.scholarrock.com
investors.scholarrock.com/news-releases/news-release-details/scholar-rock-announces-new-preclinical-data-srk-439-showing/Scholar Rock Announces New Preclinical Data for SRK-439 ...
The efficacy and safety of SRK-439 have not been established and SRK-439 has not been approved for any use by the FDA or any other regulatory agency. About ...
3.
clinicaltrialvanguard.com
clinicaltrialvanguard.com/news/scholar-rock-announces-preclinical-data-for-srk-439/Scholar Rock Announces Preclinical Data for SRK-439
It is being developed for cardiometabolic disorders, including obesity. Preclinical data suggest SRK-439 may preserve lean mass during weight ...
Scholar Rock Reports Positive Phase 2 EMBRAZE Trial ...
... SRK-439's potential in various neuromuscular disorders. The efficacy and safety of SRK-439 have not been established and SRK-439 has not ...
5.
synapse.patsnap.com
synapse.patsnap.com/article/scholar-rock-unveils-preclinical-data-on-srk-439-showing-increased-lean-mass-and-fat-loss-with-metforminScholar Rock Unveils Preclinical Data on SRK-439 ...
This compelling evidence suggests that SRK-439 could improve body composition and support healthier weight management, particularly in the ...
A Single- and Multiple-Ascending Dose Study of SRK-439 ...
Evaluate the safety and tolerability of single and multiple SRK-439 SC dose administration in healthy adult participants, Changes from baseline ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.